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Since i t s  d iscovery  over  50 years  ago, growth hormone (GH) has  a t t r a c t e d  
t h e  a t t e n t i o n  of both c l i n i c a l  and b a s i c  r e s e a r c h e r s  a l i k e .  The hormone 
accounts  f o r  20% of t h e  t o t a l  p r o t e i n  contained i n  t h e  a n t e r i o r  p i t u i t a r y  
gland. F u r t h e r ,  some 35-50% of t h e  s i x  d i f f e r e n t  hormone producing c e l l  t y p e s  
are  committed s p e c i f i c a l l y  t o  t h e  s y n t h e s i s  of GH. Mil l igram q u a n t i t i t e s  of 
GH are present  i n  t h e  human p i t u i t a r y  gland whereas only microgram q u a n t i t i e s  
of t h e  f i v e  o t h e r  p e p t i d e  hormones are contained i n  t h i s  500 mg, bean-shaped 
s t r u c t u r e .  Why should t h e r e  be such a d i s p r o p o r t i o n a t e  amount of GH? 
A s  t h e  techniques  t o  s tudy  ce l l s  and hormone molecules became more 
s e n s i t i v e ,  it a l s o  became c l e a r  t h a t  h e t e r o g e n e i t y  was a landmark of p i t u i t a r y  
GH. The p i c t u r e  t h a t  i s  emerging i n d i c a t e s  t h a t  s e v e r a l  v a r i a n t  forms of t h e  
hormone molecule e x i s t  w i t h i n  the gland a s  w e l l  as i n  the blood stream. N e w  
r e s e a r c h  a l s o  i n d i c a t e s  t h a t  t h e s e  v a r i a n t  forms possess  unique b i o l o g i c a l  
a c t i v i t i e s .  F i n a l l y ,  t h e r e  i s  evidence t o  sugges t  t h a t  GH producing ce l l s  are 
a l s o  f u n c t i o n a l l y  heterogenous.  Our NASA sponsored r e s e a r c h  d e a l s  d i r e c t l y  
w i t h  t h e s e  i s s u e s  i n  both t h e  human and ra t  p i t u i t a r y  gland. We b e l i e v e  t h a t  
t h e  l a r g e  percentages  of ce l l s  committed t o  GH product ion,  taken  t o g e t h e r  with 
t h e  s i z e a b l e  numbers of v a r i a n t  forms of GH, o f f e r  g r e a t  f l e x i b i l i t y  t o  t h e  
"GH system". It is tempting t o  s p e c u l a t e  t h a t  t h i s  f l e x i b i l i t y  h e l p s  t h e  body 
meet t h e  v a r i e d  metabol ic  demands placed on it .  Textbooks d e s c r i b e  how GH 
increases muscle mass, i n c r e a s e s  breakdown of f a t ,  decreases  uptake of 
carbohydra te  i n t o  ce l l s  and i n c r e a s e s  c e l l  d i v i s i o n .  I n  l i g h t  of t h e s e  
numerous a c t i v i t i e s ,  t h e  r e c e n t  claim t h a t  s y n t h e t i c  human GH " w i l l  soon be 
used t o  make s h o r t  c h i l d r e n  t a l l e r  and, p o s s i b l y ,  h e l p  d i e t e r s  l o s e  f a t  and 
make ag ing  people  look young" (1) i s  t h e r e f o r e  not  s u r p r i s i n g .  
S p a c e f l i g h t  provides  a unique environment which impacts t h e  GH system on 
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s e v e r a l  l e v e l s .  F i r s t ,  GH c o n t r o l s  muscle and bone metabolism, two t i s s u e s  
known t o  be n e g a t i v e l y  a f f e c t e d  i n  f l i g h t .  
it has obvious ly  evolved under t h e  cons t an t  f o r c e  of g r a v i t y .  Evidence i s  
beginning  t o  accumulate t h a t  c e l l  f u n c t i o n ,  i n  t h e  absence of g r a v i t y ,  i s  
a l t e r e d .  Th i rd ,  space  b iop rocess ing  t a k e s  advantage of t h e  l a c k  of convec t ive  
f o r c e s  i n  product ion  of m a t e r i a l s  of medical re levance .  Our NASA sponsored 
r e s e a r c h e s  on GH touch on a l l  t h r e e  of t h e s e  l e v e l s .  
Second, c e l l u l a r  " l i f e "  as we know 
Before summarizing our exper imenta l  approaches and r e s u l t s ,  i t  is 
impor tan t  t o  h i g h l i g h t  t he  unde r ly ing  theme of t h i s  work, - v iz .  t h e  importance 
of t h e  assay system used t o  measure GH. Indeed, a dichotomy between bioassay- 
a b l e  and immunoassayable GH was recognized over  10 years ago (2 ) .  While t h e  
c e l l u l a r  and molecular b a s i s  f o r  t h i s  dichotomy remain unreso lved ,  our e f f o r t s  
show t h a t  i t  unques t ionably  e x i s t s .  Our p rogres s  is summarized below. 
I. Sepa ra t ion  of GH c e l l s .  
The p i t u i t a r y  gland i s  markedly heterogeneous wi th  r e s p e c t  t o  c e l l  type.  
Over t h e  l a s t  20 yea r s  we have developed s e v e r a l  methods t o  p u r i f y  and s tudy  
GH cel ls .  These c e l l  s e p a r a t i o n  methods a r e  now b r i e f l y  reviewed. S p e c i a l  
emphasis i s  p laced  on the  d i f f e r e n t  GH assay  methods used t o  e v a l u a t e  t h e  
performance of t h e s e  ce l l s  once they are i s o l a t e d .  
A. Cell  Sepa ra t ion  & Sedimentation. 
Our l a b o r a t o r y  was the  f i r s t  t o  apply t h e  techniques  of v e l o c i t y  
sed imen ta t ion  a t  u n i t  g r a v i t y  and d e n s i t y  g r a d i e n t  c e n t r i f u g a t i o n  t o  p i t u i t a r y  
t i s s u e  ( s e e  ( 3 )  ( 4 )  f o r  reviews).  An impor tan t  outgrowth of t h e s e  experiments 
was t h e  obse rva t ion  t h a t  two subpopula t ions  of somatotrophs (GH c e l l s )  could 
be r o u t i n e l y  s e p a r a t e d  on t h e  b a s i s  of t h e i r  d i f f e r e n c e s  i n  d e n s i t y  (5) .  Key 
d i f f e r e n c e s  i n  c e l l  morphology and c e l l  f u n c t i o n  of t h e s e  subpopula t ions  are 
b r i e f l y  summarized i n  Table 1. It is impor tan t  t o  note  t h a t  a l l  of t h e  GH 
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s e c r e t i o n  d a t a  i n  t h a t  o r i g i n a l  s tudy  were ob ta ined  us ing  an e s t a b l i s h e d  GH 
radioimmunoassay. Can t h e  dichotomy between immunoassayable and b ioassayab le  
GH, desc r ibed  above, be a t t r i b u t e d  t o  d i f f e r e n t i a l  r e l e a s e  of GH forms from 
Type I VS. I1 somatotrophs? Many experiments were done t o  t es t  t h i s  
p o s s i b i l i t y  and t h e  d a t a  i n  Fig. 1 sugges t  t h a t  t h i s  i s  indeed t h e  case  ( 6 ) .  
I n  t h i s  exper imenta l  series, GH r e l e a s e d  from type  I VS. I1 c e l l s  i n t o  t i s s u e  
c u l t u r e  medium w a s  assayed by s t anda rd  immunological ( I )  procedures o r  by t h e  
r a t  t i b i a l  l i n e  b ioassay  (B) .  This  b ioassay ,  o r i g i n a l l y  desc r ibed  i n  1949, 
i s  based on t h e  a c t i o n  of GH t o  promote widening of t h e  t i b i a l  ep iphysea l  
c a r t i l a g e  p l a t e  of hypophysectomized ra ts  a f t e r  e i g h t  i n j e c t i o n s  over f o u r  
days. Q u a n t i t a t i o n  i s  accomplished by o c u l a r  micrometry of s t a i n e d  growth 
p l a t e s .  While t h e  procedure s u f f e r s  from l a c k  of s e n s i t i v i t y  (5  ug ) ,  i t  is 
t h e  accepted  b ioassay  f o r  GH. The d a t a  i n  Fig.  1 e s t a b l i s h  t h a t  GH i n i t i a l l y  
r e l e a s e d  from type I1 somatotrophs has a much h ighe r  B / I  r a t i o  than  type  I 
c e l l s .  
It can be argued t h a t  t h e  "u l t imate"  b ioassay  one could use t o  tes t  t h e  
a c t i v i t y  of GH r e l e a s e d  from type  I VS. I1 somatotrophs would be t h e i r  
r e i m p l a n t a t i o n  i n t o  animals d e f i c i e n t  i n  GH ( i . e .  a hypophysectomized r a t ) .  
A s  we had developed t h e  methodology t o  do t h i s  unique type  of imp lan ta t ion  
experiment a t  about t h e  same t i m e  t h e  d a t a  i n  Fig. 1 were being c o l l e c t e d ,  
t h e  experiment w a s  r e l a t i v e l y  s t r a i g h t f o r w a r d .  The implan ta t ion  method i t s e l f  
i n v o l v e s  e n c a p s u l a t i o n  of c e l l s  ( u s u a l l y  2 . 5 ~ 1 0 ~  i n  1.8 U 1  of c u l t u r e  medium) 
i n  10 mm long  XM-50 Amicon hollow f i b e r s .  These f i b e r s  are composed of a 
polyvinylchloride-acrylonitrile copolymer and have an i n t e r n a l  d iameter  of 
e i t h e r  500 or  1100 Um. The i r  unique f e a t u r e  i s  t h a t  t h e  lumen of t h i s  f i b e r  
i s  l i n e d  with a t h i n  membrane con ta in ing  pores  of w e l l  de f ined  s i z e ,  v iz .  40A0 
(?5%).  By v i r t u e  of t h i s  pore s i z e ,  only s p h e r i c a l  molecules <50,000 d a l t o n s  
-
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can t h e o r e t i c a l l y  pass  through t h e  membrane. 
hormone r e l e a s e d  from encapsu la t ed  c e l l s  could i n  theo ry  pass  through t h e  
hollow f i b e r  and e n t e r  t h e  animals blood s t ream t o  d e l i v e r  GH t o  i t s  u l t i m a t e  
b i o l o g i c a l  t a r g e t ( s ) .  
S ince  GH has a mass of 22 kd, 
Shown i n  Fig.  2 are micrographs of t h e  hollow f i b e r  as w e l l  a s  t h e  
appearance of c e l l s  w i th in  t h e  f i b e r  p r i o r  t o  imp lan ta t ion .  The resu l t s  of an  
experiment designed t o  tes t  t h e  b i o l o g i c a l  responses of GH r e l e a s e d  from Type 
I vs. I1 somatotrophs i n  t h i s  hollow f i b e r  system is o f f e r e d  i n  Fig. 3.  These 
d a t a  show t h a t  animals implanted with type  I1 somatotrophs a )  gained more body 
weight ,  b )  had inc reased  t i b i a l  ep iphysea l  width and c )  had inc reased  muscle 
weight.  S ince  t h e  r e l a t i v e  percentage  i n c r e a s e s  i n  muscle mass were g r e a t e r  
t h a n  i n c r e a s e s  i n  t o t a l  body weight,  we conclude t h a t  l e a n  body mass was 
s t i m u l a t e d  by hormone r e l e a s e d  from type  I1 cells.  We have seen  t h i s  k ind  of 
r e s u l t  i n  s e v e r a l  a d d i t i o n a l  experiments.  D e t a i l s  on t h i s  unique a p p l i c a t i o n  
of t h e  hollow f i b e r  method a r e  t o  be found i n  (7,8). 
B. S e p a r a t i o n  of ce l l s  & l i g h t  scat ter  -- 
Cytoplasmic g r a n u l a t i o n  c o n s t i t u t e s  a dominant f e a t u r e  of p i t u i t a r y  
c e l l s  (Fig.  4 ) .  We reasoned t h a t  t h i s  f e a t u r e  might be used t o  advantage when 
s c a t t e r i n g  of laser l i g h t  w a s  used a s  t h e  probe. This  i d e a  has been t e s t e d  
u s i n g  an EPICS V c e l l  s o r t e r  equipped wi th  an argon i o n  l a s e r  tuned t o  t h e  488 
nm l i n e  a t  150 mW. We have been a b l e  t o  show t h a t  t h e  back sca t te r  s i g n a l  
produced from l i v i n g  ce l l s  ( a  complex f u n c t i o n  of d i f f r a c t i v e ,  r e f l e c t i v e  and 
r e f r a c t i v e  components) was indeed r e l a t e d  t o  t h e  degree of cy toplasmic  
g r a n u l a t i o n .  Shown i n  t h e  top  panel  of Fig. 5 a r e  t h e  back s c a t t e r  (PLS-X 
a x i s )  and forward ang le  l i g h t  s c a t t e r  (FALS-Y a x i s )  s i g n a l s  produced by t h e  
t o t a l  mixture of l i v i n g  p i t u i t a r y  c e l l  t ypes  viewed from d i f f e r e n t  
p r o j e c t i o n s .  Also shown i n  Fig.  5 a r e  t h e  l i g h t  sca t te r  r i d g e s  a f t e r  
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s e p a r a t i o n  us ing  t h e  c e l l  s o r t  mode of t h e  f low cytometer. S t a i n i n g  a n a l y s i s  
r evea led  t h a t  a )  82% of t h e  ce l l s  i n  reg ion  C were GH c e l l s ,  b )  65-75% of t h e  
c e l l s  i n  reg ion  B were PRL ce l l s  and c )  80% of t h e  cel ls  i n  r eg ion  A were 
e i t h e r  f o l l i c u l a r  c e l l s ,  macrophages, o r  e n d o t h e l i a l  ce l l s  (9,lO). 
The flow cytometer has proven t o  be an extremely u s e f u l  t o o l  no t  on ly  f o r  
t h e  s e p a r a t i o n  of d i f f e r e n t  l i v e  p i t u i t a r y  c e l l  t y p e s  ( a s  demonstrated by Fig.  
5 ) ,  but a l s o  i n  an a n a l y t i c a l  mode where t h e  percentage  d i s t r i b u t i o n s  of f i x e d  
and s t a i n e d  p i t u i t a r y  c e l l  t ypes  can be o b j e c t i v e l y  determined with 
cons ide rab le  s t a t i s t i c a l  accuracy  i n  a very few minutes (11). 
We have not as y e t  had t h e  oppor tun i ty  t o  a t t e m p t  t o  s o r t  t ype  I and type  
I1 somatotrophs us ing  f low cy tone t ry .  However, t h e  ins t rument  i s  proving  t o  be 
ex t remely  u s e f u l  f o r  ana lyz ing  c e l l s  s e p a r a t e d  by o t h e r  methods ( s e e  l a t e r ) .  
C. C e l l  s e p a r a t i o n  by e l e c t r o p h o r e s i s .  
Our e a r l y  a t t e m p t s  t o  e l e c t r o p h o r e t i c a l l y  separate p i t u i t a r y  c e l l s  
employed t h e  d e n s i t y  g r a d i e n t  e l e c t r o p h o r e s i s  method of Boltz and Todd (12 ) .  
This  method r equ i r ed  i n s e r t i o n  of c e l l s  a t  t h e  bottom of an i s o t o n i c  d e n s i t y  
g r a d i e n t  which c o n s i s t s  of a 5.4-6.5% suc rose  g r a d i e n t  (bottom t o  t o p )  and 
2.0-8.0% F i c o l l  g r a d i e n t  ( t o p  t o  bottom). E l e c t r o p h o r e s i s  w a s  i n  t h e  upward 
d i r e c t i o n .  We obta ined  evidence t h a t  type  I1 somatotrophs might have a 
d i f f e r e n t  e l e c t r o p h o r e t i c  m o b i l i t y  from ce l l s  i n  t h e  type  I r eg ion  (13). Cells 
i n  t h e  somatotroph en r i ched  f r a c t i o n  had lower e l e c t r o p h o r e t i c  m o b i l i t i e s  t han  
t h o s e  c e l l s  recovered from t h e  band I a rea .  However, a d d i t i o n a l  a n a l y t i c a l  
p rocedures ,  % microscopic  e l e c t r o p h o r e s i s  u s i n g  a Ze i s s  'cytopherometer '  and 
automated l i g h t  s c a t t e r i n g  e l e c t r o p h o r e s i s  u s i n g  a Pen Kem 3000 Automated 
E l e c t r o k i n e t i c  Analyzer were a l s o  t r i e d .  Ne i the r  of t h e s e  two ins t rumen t s  was 
a b l e  t o  d i s t i n g u i s h  s i g n i f i c a n t  d i f f e r e n c e s  i n  e l e c t r o p h o r e t i c  m o b i l i t i e s  
between band I and band I1 c e l l s .  P re t r ea tmen t  of t h e  cel ls  wi th  s e c r e t o r y  
52 
a g e n t s  a l s o  had no s i g n i f i c a n t  e f f e c t s  on t h i s  r e s u l t  (see 13 f o r  a d d i t i o n a l  
d e t a i l s . )  
I n  1981 t h e  i s s u e  of whether GH ce l l s  could be e l e c t r o p h o r e t i c a l l y  
s e p a r a t e d  from o t h e r  t ypes  of hormone producing ce l l s  was r e i n v e s t i g a t e d  when 
t h e  cont inuous f l o w  e l e c t r o p h o r e t i c  s e p a r a t o r ,  (CFES) designed and b u i l t  by t h e  
McDonnell-Douglas As t ronau t i c s  Corp., became a v a i l a b l e  f o r  our  use. The 
i n t e r e s t e d  r eade r  i s  r e f e r r e d  t o  t h e  c h a p t e r  by Todd e t .  a l .  i n  t h i s  volume f o r  
i n fo rma t ion  r ega rd ing  the d e s c r i p t i o n  and o p e r a t i o n  of t h i s  device.  
- -  
E a r l y  t r i a l s  i n  1981-82 involved p i t u i t a r y  ce l l  s e p a r a t i o n s  u t i l i z i n g  a 
low c o n d u c t i v i t y  t r ie thanolamine-potass ium acetate  b u f f e r ,  pH 7.25, 300 
m O s m / l i t e r  i n  t h e  CFES device  a t  a f low rate  of 20 ml/min. The r e s u l t s  of 
t h e s e  e a r l y  t r i a l s  were encouraging i n  t h a t  they showed t h a t  GH ce l l s  were 
among t h e  most mobile and t h a t  GH c e l l s  a f t e r  CFES produced hormone and 
r e l e a s e d  i t  i n t o  t h e  c u l t u r e  medium. These r e s u l t s  were publ i shed  i n  ( 1 3 )  and 
are  not  reviewed here. A second, more e x t e n s i v e  exper imenta l  series was 
r e c e n t l y  completed and publ i shed  (14 ) .  Analyses of c e l l s  i n  t h e  d i f f e r e n t  
f r a c t i o n s  inc luded  a )  count ing  of GH and PRL con ta in ing  ce l l s  t o  determine 
t h e i r  percentage  d i s t r i b u t i o n s  b)  measurement of i n t r a c e l l u l a r  horomone by 
immunoassay and c )  c e l l  c u l t u r e  t o  e s t a b l i s h  t h e  s e c r e t o r y  c a p a b l i t y  of ce l l s  
a f t e r  CFE. The r e s u l t s  of f o u r  exper iments ,  each u t i l i z i n g  g lands  from -50 
ra t s ,  are g iven  i n  Fig. 6. With no c u r r e n t  a p p l i e d  cel ls  emerged from t h e  
chamber wi th in  two o u t l e t s  (1.6 mm) of the i n l e t  po r t .  With c u r r e n t  a p p l i e d ,  
a l l  p i t u i t a r y  ce l l s  showed anodal  mig ra t ion ,  a ma jo r i ty  being spread  over  40-50 
o u t l e t  t ubes  (Fig.  6 pane ls  A,F,K,N). I n t r a c e l l u l a r  GH l e v e l s  were 4-8 times 
h i g h e r  i n  more mobile f r a c t i o n s  (Fig.  6 ,  pane ls  B,G,O). F u r t h e r ,  60-80% of 
t h e  more mobile ce l l s  were i d e n t i f i e d  as con ta in ing  GH by immunocytochemistry 
(Fig.  6 ,  pane l s ,  C ,H and L). I n  one experiment ,  i n t r a c e l l u l a r  LH, FSH and TSH 
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were a l s o  measured and found t o  be l o c a l i z e d  i n  anodal f r a c t i o n s  (Fig.  6 
pane l s  P,Q and R). F i n a l l y ,  i n  experiments 3 and 4 ,  GH and PRL l e v e l s  i n  
c u l t u r e  medium a f t e r  e l e c t r o p h o r e s i s  were measured by immunoassay. I n  
g e n e r a l ,  hormone output  r e f l e c t e d  GH/PRL enrichments as es t imated  by RIA o r  
immunocytochemistry; a r e s u l t  which a t t e s t s  t o  t h e  f i d e l i t y  of s e p a r a t i o n  
estimates as w e l l  as i n f e r r i n g  c e l l  v i a b i l i t y  a f t e r  CFE. The issue of t h e  
b i o l o g i c a l  VS. immunological a c t i v i t y  of t h e  GH r e l e a s e d  from c e l l s  s e p a r a t e d  
by CFE was a l s o  s t u d i e d  i n  Exp. 84 of Fig. 6.  The d a t a ,  summarized i n  Fig.  7 ,  
e s t a b l i s h  t h a t  somatotrophs i n  t h e  more anodal  f r a c t i o n s  release GH which 
i s  more b i o a c t i v e  than  cor responding  somatotrophs i n  t h e  less mobile areas. On 
t h e  b a s i s  of t h e s e  a s say  r e s u l t s  it is tempting t o  s p e c u l a t e  t h a t  t ype  I1 
somatotrophs are more e l e c t r o p h o r e t i c a l l y  mobile t han  type  I GH ce l l s  i n  t h e  
McDonnell Douglas device .  
A s  d i scussed  p rev ious ly  ( s e c t i o n  B) t h e  p o t e n t i a l  of t h e  f low cytometer 
i n  ana lyz ing  c e l l s  a f t e r  CFES has only r e c e n t l y  begun t o  be i n v e s t i g a t e d .  For 
i l l u s t r a t i v e  purposes,  t h e  resul ts  of a p re l imina ry  experiment are o f f e r e d  i n  
F igs .  8 and 9. The mob i l i t y  p r o f i l e  of t h e  t o t a l  c e l l  popu la t ion  i s  shown i n  
Fig.  8 ( top ) .  Counting t h e  s t a i n e d  ce l l s  i n  t h i s  experiment by flow 
cytometry showed t h a t  GH ce l l s  tended t o  be found i n  two r eg ions  [ f r a c t i o n s  
11-15 and 16-20; Fig. 8 (middle) ]  whi le  PRL c e l l s  were a l s o  found i n  two 
r e g i o n s ,  but they  were of lower e l e c t r o p h o r e t i c  mob i l i t y  [ f r a c t i o n s  6-11 and 
12-14; Fig. 8 (bottom)].  R e s u l t s  of two parameter ana lyses  of GH-stained ce l l s  
i n  f r a c t i o n  5 VS. f r a c t i o n  19 are g iven  i n  Fig. 9 .  I n  t h i s  f i g u r e  t h e  l o g  of 
t h e  green  f l u o r s c e n c e  s t a i n i n g  (LPGFL), which can be a t t r i b u t e d  s p e c i f i c a l l y  t o  
GH ce l l s ,  i s  shown on t h e  X a x i s  whereas t h e  forward angle  l i g h t  s c a t t e r ,  
a t t r i b u t e d  s p e c i f i c a l l y  t o  c e l l  s i z e ,  is  shown on t h e  Y axis. All of t h e  
I1 even t s "  shown i n  Fig. 9 (29 ,999  f o r  F r .  #5 and 14,338 f o r  F r .  19)  can be 
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unequivoca l ly  a t t r i b u t e d  t o  ce l l  s i g n a l s  s i n c e  they were "gated" on red 
f l u o r e s c e n c e  s i g n a l s  genera ted  u s i n g  propidium iodine .  The predominant 
d i f f e r e n c e  between GH ce l l s  i n  F r s .  5 VS. 19 i s  t h a t  a ma jo r i ty  of GH c e l l s  i n  
F r .  19 a r e  l a r g e  and w e l l  de f ined  ( a r e a  l a b e l e d  by v )  whereas small, less 
i n t e n s e l y  s t a i n e d  GH cel ls  a r e  common t o  both f r a c t i o n s  ( i d e n t i f i e d  by *I. 
What bea r ing  and r e l a t i o n s h i p s  do t h e  p i t u i t a r y  c e l l  s e p a r a t i o n s  by CFES 
have on t h e  i s s u e  of microgravity-based r e sea rch?  I n  l i g h t  of t h e  d i f f e r e n t  
d e n s i t i e s  of t h e  v a r i o u s  hormone-producing ce l l  types ,  we were concerned t h a t  
t h i s  parameter might c o n t r i b u t e  t o  t h e  apparent  e l e c t r o p h o r e t i c  s e p a r a t i o n s  
a c t u a l l y  achieved ( e s p e c i a l l y  those  on t h e  CFES device) .  However, t h e  r e s u l t s  
of our mic rograv i ty  experiment on board STS-8 i n  September 1983, ( i d e n t i f i e d  as 
Exp. #2 i n  Fig. 6 ) ,  e s t a b l i s h  t h e  g e n e r a l  p r i n c i p l e  t h a t  we have s e e n  
c o n s i s t e n t l y ,  viz--that a ma jo r i ty  of t h e  GH c e l l s  are more e l e c t r o p h o r e t i c a l l y  
mobile t h a n  t h e  PRL-containing cells .  Therefore  we f e e l  conf iden t  i n  
concluding t h a t  t h e  ne t  charge on t h e  s u r f a c e  of most somatotrophs i s  
s i g n i f i c a n t l y  d i f f e r e n t  from t h a t  of most PRL c e l l s .  This  n o n - t r i v i a l  r e s u l t  
w i l l  be confirmed, optimized and cons ide rab ly  extended i n  a f u t u r e  mic rograv i ty  
based s e p a r a t i o n  experiment (see l a t e r ) .  
11. P u r i f i c a t i o n  of human growth hormone (hGH). 
- 
I n  a w e l l  known textbook on Endocrinology one f i n d s  t h e  fo l lowing  
s t a t e m e n t s  concerning GH i n  t h e  human p i t u i t a r y  gland a f t e r  dea th :  
"For tuna te ly ,  t h e  human p i t u i t a r y  i s  p a r t i c u l a r l y  r i c h  i n  
GH, and t h e  somato t ropic  g ranu le  resists a u t o l y t i c  
d i s s o l u t i o n  a f t e r  dea th .  Desp i t e  t h e  f a c t  t h a t  radio- 
immunoassays sugges t  a much h ighe r  c o n t e n t ,  t h e  y i e l d  of 
somato t ropin  wi th  p r e s e n t  e x t r a c t i o n  methods i s  between 8 
and 16% of t h e  dry  weight of human p i t u i t a r i e s ,  equ iva len t  
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t o  4-8 mg of hormone/gland. 
con ten t  wi th  age a r e  ev ident . "  
No s i g n i f i c a n t  changes i n  GH 
A number of y e a r s  ago t h e  Na t iona l  P i t u i t a r y  Agency was e s t a b l i s h e d  f o r  
t h e  purposes of p u r i f y i n g  hGH from pos t  mortem glands  and provid ing  t h i s  
m a t e r i a l  f o r  c l i n i c a l  medicine. Over t h e  y e a r s ,  many c h i l d r e n  of s h o r t  
s t a t u r e  bene f i t ed  s i g n i f i c a n t l y  from i n j e c t i o n s  of t h e  p u r i f i e d  hormone. I n  
f a c t ,  t h e  Nat iona l  P i t u i t a r y  Agency processed  about 50,000 p i t u i t a r i e s  a y e a r ,  
supp ly ing  t h e  hGH from them t o  about 5000 c h i l d r e n .  Supply d id  not keep pace 
wi th  demand. Quite r e c e n t l y  t h i s  s i t u a t i o n  changed d rama t i ca l ly  when t h e  
program r e s p o n s i b l e  f o r  p u r i f i c a t i o n  of hGH w a s  s h u t  down when t h e  dea ths  of 
t h r e e  p a t i e n t s  r e c e i v i n g  hGH were a t t r i b u t e d  t o  a slow v i r u s  contaminat ing  t h e  
hormone p r e p a r a t i o n s  (15).  I n  t h e  F a l l  of 1985 t h e  Food and Drug 
Admin i s t r a t ion  gave i t s  approval  € o r  use  of a g e n e t i c a l l y  engineered  v e r s i o n  
of hGH produced by Genentech. P a t i e n t s  a r e  c u r r e n t l y  r e c e i v i n g  t h i s  hGH a t  a 
c o s t  of $10,00O/year f o r  t h r e e  in j ec t ions /week .  
I n  s e c t i o n  I of t h i s  r e p o r t  we p resented  evidence t h a t  t h e r e  were a t  
least  two forms of GH s e c r e t e d  from subpopula t ions  of ra t  p i t u i t a r y  
somatotrophs.  
t h a n  t h e  o the r .  Our c u r r e n t  r e sea rch  e f f o r t s  with human p i t u i t a r y  GH are 
based on a similar i d e a ,  v i z  t h a t  a d i s c r e t e  form of hGH with high biopotency 
i s  conta ined  wi th in  t h e  human p i t u i t a r y .  Our goa l  i s  t o  p u r i f y  t h i s  m a t e r i a l .  
The d i f f e r e n t  approaches which a r e  be ing  used are now b r i e f l y  summarized. 
One had a s i g n i f i c a n t l y  h ighe r  bioactivity/immunoactivity r a t i o  
-
Approach #l. Continuous Flow E l e c t r o p h o r e s i s  (CFE) of human p o s t  mortem 
p i t u i t a r y  g ranu le s .  
Shown i n  Fig.  10 is  an e l e c t r o n  micrograph of t h e  appearance of human 
p i t u i t a r y  t i s s u e  e i g h t  h r s  a f t e r  dea th .  The dominant f e a t u r e  of t h i s  t i s sue ,  
as i s  ev iden t  from t h e  f i g u r e ,  i s  t h a t  i t  is l aden  with hormone-containing 
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granu les .  We reasoned t h a t  CFE of suspens ions  con ta in ing  such p a r t i c l e s  might 
be a u s e f u l  approach t o  t h e  i s o l a t i o n  of hGH with h igh  biopotency. The 
experiment involved a )  p r e p a r a t i o n  of homogenate of 11 h r  pos t  mortem t i s s u e  
i n  i s o t o n i c  s u c r o s e ,  b) p r e p a r a t i o n  of a crude g ranu le  f r a c t i o n  by 
c e n t r i f u g a t i o n  a t  20,000 xg, c )  washing of t h e  p e l l e t  i n  CFES b u f f e r ,  d )  CFE 
s e p a r a t i o n  (ET150), e )  c o l l e c t i o n  of m a t e r i a l  from CFE i n t o  200 i n d i v i d u a l  
t ubes  con ta in ing  a l k a l i  ( t o  d i s r u p t  g r a n u l e s ) ,  f )  radioimmunoassay of t h e  
s o l u b i l i z e d  material i n  each of t h e  200 tubes  and f i n a l l y  g )  pool ing  of tubes  
f o r  assay of b i o a c t i v e  GH v i a  t h e  t i b i a l  l i n e  assay .  Shown i n  Fig. 11 i s  t h e  
p r o f i l e  of immunoreactive hGH a f t e r  continuous f l o w  e l e c t r o p h o r e s i s .  
each  of 200 tubes  were ana lyzed ,  only # ' s  90-140 a r e  shown s i n c e  t h e  o t h e r s  
con ta ined  no d e t e c t a b l e  a c t i v i t y .  C l e a r l y ,  t h e r e  i s  a sha rp ,  symmetrical  peak 
encompassed by tubes  100-109 which c o n t a i n  t h e  bulk of t h e  immunoactive 
hormone. The p o s i t i o n  where most of t h e  b i o a c t i v e  hGH was recovered was 
c l e a r l y  somewhat d i f f e r e n t  (Fig.  12). While 75% of t h e  b i o a c t i v e  hormone was 
recovered  i n  tubes  88-113, t h e  hormone i n  combined f r a c t i o n  #4 ( tubes  114-200) 
w a s  obvious ly  en r i ched  i n  b i o a c t i v i t y .  
Although 
Approach #2. F r a c t i o n a t i o n  of hGH conta ined  i n  a l k a l i n e  e x t r a c t s  of 
human pos t  mortem p i t u i t a r y  by h igh  performance l i q u i d  chromatography (HPLC). 
On t h e  b a s i s  of ea r l ie r  f i n d i n g s  by E l l i s  and Grindeland which sugges ted  
t h a t  b i o a c t i v e  ra t  GH might be of cons ide rab ly  h ighe r  apparent  molecular 
weight t han  t h e  w e l l  c h a r a c t e r i z e d  monomeric 22 kD form, some experiments have 
been done us ing  HPLC on a l k a l i n e  e x t r a c t s  of human pos t  mortem p i t u i t a r y  
t i s s u e .  The r e s u l t s  of one such experiment a r e  g iven  in Fig. 13. Shown i n  
t h e  top  p o r t i o n  of t h i s  f i g u r e  is t h e  OD 214 nm of t h e  g e n e r a l  p r o t e i n  p r o f i l e  
a f t e r  HPLC. 
f r a c t i o n  areas i n d i c a t e d  are: f r .  1 ,  void volume; f r .  2 >117kD; f r .  3 ,  40-117 
Approximate molecular weights of material e l u t i n g  i n  t h e  pooled 
57 
kD; and f r .  4 <40kD. Shown i n  t h e  lower p o r t i o n  of Fig. 13 a r e  d a t a  l i s t i n g  
t h e  con ten t s  of p r o t e i n ,  immunoassayable and b ioassayab le  hormone i n  t h e s e  
f r a c t i o n s .  I n  t h i s  exper imenta l  series, b ioassayab le  GH was measured by t h e  
3 T 3  c e l l  ad ipogenic  a s say  of Nixon and Green (16).  The d a t a  confirm t h e  
e a r l i e r  obse rva t ions  of E l l i s  and Grindeland i n  t h a t  t h e r e  i s  a h igh  molecular  
weight form of t h e  hormone which is  en r i ched  i n  b i o a c t i v i t y .  
Approach 13. F r a c t i o n a t i o n  of hGH conta ined  i n  a l k a l i n e  e x t r a c t s  of 
human pos t  mortem p i t u i t a r y  by HPLC and CFES. 
S ince  CFES o f f e r e d  promise i n  t h e  s e p a r a t i o n  of a GH form i n  s e c r e t o r y  
g r a n u l e s  with h igh  B / I  a c t i v i t y  (Fig.  12) we reasoned t h a t  a combination of 
t h e  HPLC and CFES techniques  might prove i n t e r e s t i n g .  Accordingly,  an  e x t r a c t  
of pos t  mortem p i t u i t a r y  g land  was f r a c t i o n a t e d  by HPLC. A s  before  (Fig.  13) 
a high molecular weight f r a c t i o n  w a s  ob ta ined  which had 23 ug of b i o a c t i v e  
hormone and 2.8 Pg of immunoactive hormone. Th i s  material w a s  f r a c t i o n a t e d  by 
CFES i n t o  200 i n d i v i d u a l  tubes  and pooled on t h e  b a s i s  of 15 tubes / a s say  
f r a c t i o n .  R e s u l t s  concerning t h e  d i s t r i b u t i o n  of b i o l o g i c a l l y  a c t i v e  hormone 
(3T3 a s s a y )  i n d i c a t e d  t h e  s u r p r i s i n g  r e s u l t  t h a t  -50% of t h e  b i o a c t i v e  hormone 
showed ca thoda l  mig ra t ion  (Fig.  14).  Although not  shown on t h i s  f i g u r e ,  on ly  
20% of t h e  t o t a l  immunoactive hormone was a s s o c i a t e d  with material i n  combined 
f r a c t i o n s  1-5. A major peak of immunoactive hGH was a s s o c i a t e d  wi th  combined 
f r a c t i o n  8. These resul ts  a g a i n  show t h e  good p o t e n t i a l  of t h e  CFES dev ice  i n  
t h e  f r a c t i o n a t i o n  of hGH with h igh  b i o a c t i v i t y .  
Approach 84. Sepa ra t ion  of b i o a c t i v e  human growth hormone by a f f i n i t y  
chromatography. 
The r e s u l t s  of each of t h e  t h r e e  prev ious  approaches o f f e r  evidence t o  
suppor t  t h e  hypothes is  t h a t  t h e r e  i s  a form of t h e  hGH molecule, h igh  i n  
b i o l o g i c a l  potency, which can be i s o l a t e d  from a ma jo r i ty  of t h e  immunoactive 
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form. I f  t r u e ,  a more d i r e c t  approach f o r  t h e  i s o l a t i o n  of b i o a c t i v e  hGH would 
be a f f i n i t y  chromatography. I n  t h i s  procedure ,  t h e  hGH ant ibody is  c o v a l e n t l y  
bound t o  a column suppor t .  On pass ing  an  unknown sample c o n t a i n i n g  
immunoreactive hormone through t h e  column, t h e  immunoactive form binds  whereas 
t h e  b i o a c t i v e  form passes  through. Recovery of t h e  immunoactive form from t h e  
column is  accomplished by running a h igh  s a l t  s o l u t i o n  through t o  d i s p l a c e  
bound hormone. Only p re l imina ry  resul ts  have been obta ined  thus  f a r  u s i n g  t h i s  
approach. They are shown i n  Fig. 15 and Fig.  16. When t h e  hormone s t anda rd  
was run through t h e  a f f i n i t y  column, 99% of t h e  recovered immunoactive hGH 
bound t o  t h e  column. A s  a r e s u l t ,  t h e  B / I  a c t i v i t y  r a t i o  of t h e  p a s s  through 
material was  9 .3  (Fig.  15). When a f r e s h  a l k a l i n e  e x t r a c t  of human p i t u i t a r y  
g l and  t i s s u e  was run through t h i s  a f f i n i t y  column, 100% of t h e  immunoactive 
hormone bound t o  t h e  column while a small, but nonethe less  d e t e c t a b l e ,  amount 
of b i o a c t i v e  hormone passed through (Fig.  15). It i s  important t o  i n d i c a t e  
t h a t  t h i s  material was devoid of immunological a c t i v l t y .  [Why more b i o a c t i v e  
hGH i s  recovered than  was a p p l i e d  i s  unknown. However, i t  is  a h igh ly  
r e p e a t a b l e  obse rva t ion  and many re la te  t o  removal of a n a t u r a l  i n h i b i t o r  of 
t h i s  b i o a c t i v e  form on p u r i f i c a t i o n ] .  
The e f f i c a c y  of t h e  a f f i n i t y  chromatographic approach t o  t h e  i s o l a t i o n  
of hGH is  a l s o  shown by t h e  Western b l o t s  i n  Fig. 16. A l l  of t h e  bands seen  
i n  t h i s  f i g u r e  are r e a c t i v e  a g a i n s t  hGH an t i se rum and are, by d e f i n i t f o n  hGH. 
I d e n t i f i c a t i o n  of materials i n  l a n e s  1-6 are a s  fo l lows:  Lane 1, 
u n f r a c t i o n a t e d  hormone s t anda rd ;  l a n e  2 ,  hGH i n  hormone s t anda rd  bound t o  
a f f i n i t y  column; l a n e  3 ,  hGH i n  hormone s t a n d a r d  which passed through column; 
l a n e  4 ,  hGH i n  f r e s h  human p i t u i t a r y  e x t r a c t ;  l a n e  5, hGH i n  human p i t u i t a r y  
e x t r a c t  bound t o  column; l a n e  6,  hGH i n  human p i t u i t a r y  extract  which passed 
through t h e  a f f i n i t y  column. We i n t e r p r e t  t h e  molecular weight e s t i m a t i o n s  of 
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t h e  s t a i n e d  GH molecules t o  r e f l e c t  monomeric hGH (22kD); d imer ic  GH (-40kD) 
and trimeric aggrega te s  (-60kD). C l e a r l y ,  t h e  e f f i c a c y  of t h e  column i n  
removing t h e s e  immunoactive forms of hGH is  documented by the  d a t a  i n  Fig. 15 
and Fig.  16. 
111. Experiments p rev ious ly  done i n  microgravi ty .  
Over t h e  per iod  of 1983-1985 our group has done t h r e e  GH-related 
exper iments  on t h e  S h u t t l e .  A b r i e f  summary of t h e  f i n d i n g s  from each of 
t h e s e  t h r e e  exper iments ,  t o g e t h e r  with t h e i r  s i g n i f i c a n c e  t o  t h e  "GH system" 
as s p e c i f i c a l l y  r e l a t e d  t o  mic rograv i ty ,  are presented  i n  t h i s  s e c t i o n .  
Experiment 111. The s e p a r a t i o n  of r a t  p i t u i t a r y  GH c e l l s  from o t h e r  
hormone con ta in ing  c e l l  t ypes  was accomplished by CFES on t h e  f l i g h t  of STS-8. 
The d a t a  (Fig.  6 ,  exp. 2) showed t h a t  GH ce l l s  have a s u r f a c e  charge which 
i s  d i f f e r e n t  from p r o l a c t i n  cel ls ,  thereby  i n d i c a t i n g  t h a t  d i f f e r e n c e s  i n  c e l l  
d e n s i t y  could not e x p l a i n  t h e  s e p a r a t i o n s  a c t u a l l y  achieved on Ear th .  
While t h e  mic rograv i ty  experiment was g e n e r a l l y  s u c c e s s f u l ,  no t  a l l  of 
i t s  o r i g i n a l  o b j e c t i v e s  were m e t  s i n c e  ce l l  r e c o v e r i e s  from the  CFES dev ice  
were very low. This  s i t u a t i o n  fo rced  us  t o  pool c e l l s  i n  o r d e r  t o  have 
s u f f i c i e n t  numbers t o  do those  ana lyses  shown i n  Fig. 6. Thus, we were 
unable t o  c u l t u r e  t h e s e  s e p a r a t e d  c e l l s  f o r  t h e  purposes of de te rmining  
whether h igh  b ioproducers  were a c t u a l l y  sepa ra t ed  from t h e  low b ioproducers  i n  
mic rograv i ty .  Cons ider ing  t h e  r e s u l t s  of our second microgravi ty  experiment 
( s e e  below) t h e r e  i s  some q u e s t i o n  as t o  how wel l  t h e  high b ioproducers  might 
a c t u a l l y  f u n c t i o n  i n  space.  The need t o  repeat t h e  p i t u i t a r y  c e l l  s e p a r a t i o n  
experiment i n  microgravi ty  i s  c r i t i c a l  t o  f i n d  ou t  if t h e  sepa ra t ed  ce l l s  do 
r e t a i n  t h e i r  a b i l i t y  t o  produce b i o a c t i v e  GH. 
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Experiment 82. A pre l imina ry  p i t u i t a r y  c e l l  c u l t u r e  experiment was a l s o  
done on t h e  f l i g h t  of STS-8. This  experiment involved s t o r a g e  of d i s p e r s e d  
p i t u i t a r y  c e l l s  i n  s e a l e d  tubes  i n  middeck l o c k e r s  maintained a t  37°C. On 
recovery ,  t h e  ce l l s  were washed and c u l t u r e d  f o r  s i x  days t o  e v a l u a t e  t h e  
s e c r e t o r y  c a p a c i t y  of p r o l a c t i n  (PRL) and GH producing cel ls .  
Table 2 ,  t h e  s e c r e t o r y  a c t i v i t y  of GH c e l l s  was s e v e r e l y  compromised by 
exposure t o  mic rograv i ty ,  whi le  t h a t  of PRL c e l l s  w a s  not. Considered with 
t h e  expe r i ences  of t h e  Cogoli group wi th  regard  t o  t h e  f a i l u r e  of mic rograv i ty  
exposed lymphocytes t o  respond t o  Con A ( 1 7 )  and a l t e r a t i o n  of va r i ed  c e l l  
f u n c t i o n s  recorded on t h e  German D-1 miss ion  i n  l a t e  1985, t h e  p o s s i b i l i t y  
t h a t  t h e  l a c k  of g r a v i t y  has d i r e c t  e f f e c t s  a t  t h e  c e l l u l a r  l e v e l  appea r s  
worthy of f u r t h e r  s tudy .  I n  s p e c i f i c  r ega rd  t o  GH, t h e  i s s u e  assumes added 
importance i n  terms of t h e  documented e f f e c t s  of t h i s  hormone on f u n c t i o n  of 
muscle and bone, two t i s s u e s  known t o  be s i g n i f i c a n t l y  a f f e c t e d  by f l i g h t .  
Another p i t u i t a r y  c e l l  c u l t u r e  experiment has been approved f o r  f l i g h t  and 
c u r r e n t l y  awaits remani fes t ing .  
A s  shown i n  
Experiment #3. P i t u i t a r y  GH c e l l s  conta ined  i n  g lands  of rats flown on 
SL-3 i n  A p r i l ,  1985 were a l s o  s t u d i e d  by our group and shown t o  be d e f e c t i v e  
i n  GH s e c r e t i o n .  The results of t h i s  s tudy  (18) showed t h a t  r e l e a s e  of both 
b i o a c t i v e  and immunoactive GH from i s o l a t e d  c e l l s  a f t e r  f l i g h t  was reduced by 
about  50% r e l a t i v e  t o  a p p r o p r i a t e  ground based c o n t r o l s .  
PRL s e c r e t i o n  w a s  una f fec t ed .  I n  t h i s  r ega rd ,  t h e  SL-3 r e s u l t s  and STS-8 
r e s u l t s  r ega rd ing  a d e f e c t  i n  GH release are i n t e r n a l l y  c o n s i s t e n t .  Add i t iona l  
ev idence  sugges ted  t h a t  a h igh  molecular  weight form of t h e  GH molecule,  
e n r i c h e d  i n  b i o a c t i v i t y ,  was not  r e l e a s e d  from t h e  f l i g h t  cells .  
On t h e  o t h e r  hand, 
61 
I V .  P repa ra t ion  f o r  a f u t u r e  f l i g h t  experiment:  A i m s ,  p r o t o c o l s ,  r a t i o n a l e ,  
ground based r e s e a r c h ,  p o t e n t i a l  problems. 
A. The exper imenta l  p r o t o c o l  f o r  aim b l  of our approved ground based 
r e s e a r c h  and f l i g h t  experiment i s  g iven  below. I n  essence  t h i s  
experiment involves  the  s e p a r a t i o n  of d i f f e r e n t  r a t  p i t u i t a r y  c e l l  
types  by CFE. 
AIM 81 Experimental  Pro tocol  
ra t  p i t u i t a r y  c e l l s  
continuous f low 
e l e c t r o p h o r e s i s  
J 
f r a c t i o n s  (10-25) 
a s s a y  B / I  a c t i v i t y  chemis t ry  by c e l l u l a r  and implants  i n t o  
of s e c r e t e d  hormone f low cytometry s e c r e t e d  GH hypophysectomized 
i n  serum and serum- t o  determine a )  HPLC- ra ts  
f r e e  medium p u r i t y  of c e l l  r e v e r s e  phase 
type  i n  f r a c t i o n  b) HPLC-sizing 
c )  Western b l o t  
With t h i s  approach we should  be a b l e  t o  o b t a i n  answers t o  such q u e s t i o n s  
as : 
1. What is t h e  degree  of ce l l  p u r i f i c a t i o n  achieved  by CFE under 
c o n d i t i o n s  where e x t e n s i v e  ce l l  pool ing  is  not r equ i r ed  ( a s  it was 
on STS-8)? 
2. What a r e  t h e  B / I  a c t i v i t i e s  of GH r e l e a s e d  from t h e  
e l e c t r o p h o r e t i c a l l y  s e p a r a t e d  c e l l s ?  
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3. What are t h e  molecular forms of t h e  s e c r e t e d  GH? 
4 .  Which e l e c t r o p h o r e t i c a l l y  p u r i f i e d  popu la t ion  of GH ce l l s  i s  
capable  of r e i n i t i a t i n g  t o t a l  body growth, i n c r e a s e s  i n  muscle 
mass, and i n c r e a s e s  i n  organ weights? 
What e f f e c t  does mic rograv i ty  have on t h e  answers t o  ques t ions  5. 
1-4? 
I f  we are c o r r e c t  i n  our s u s p i c i o n  t h a t  GH ce l l s  i n  microgravi ty  expe r i ence  
a l e s i o n  i n  hormone s e c r e t i o n ,  a s u c c e s s f u l  outcome t o  t h i s  experiment w i l l  no t  
on ly  helped t o  d e f i n e  t h e  c e l l u l a r  and molecular b a s i s  of t h i s  l e s i o n ,  bu t  w i l l  
a l s o  i d e n t i f y  t h e  s p e c i f i c  GH c e l l  subpopula t ion  ( i n  terms of i t s  
e l e c t r o p h o r e t i c  m o b i l i t y )  t h a t  i s  a f f e c t e d  by microgravi ty .  
GENERAL CONSIDERATION AND -
RESEARCH- 
POTENTIAL PROBLEMS TO -- BE ADDRESSED I N  THIS -
It is obvious t h a t  t h e  exper imenta l  cond i t ions  found t o  y i e l d  optimal 
r e s u l t s  on Ea r th  should  be t h e  ones a c t u a l l y  used i n  t h e  mic rograv i ty  
experiment.  We b e l i e v e  t h a t  t h e  ce l l  ho ld ing  c o n d i t i o n s  p r i o r  t o  
e l e c t r o p h o r e s i s  should be made more compatible with t h e  physiology of t h e  a c t u a l  
c e l l  system; (e.g. under ambient tempera tures  i n  p ro ten  con ta in ing  b u f f e r s ) .  
Furthermore,  t h e  i s s u e  of t h e  use of a CFES b u f f e r  system more compatible wi th  
e x c e l l e n t  c e l l  v i a b i l i t y  needs t o  be addressed. The actual  CFES run  of t h e  
c e l l s  should  i d e a l l y  be performed e a r l y  on i n  t h e  f l i g h t .  The s e p a r a t e d  c e l l s  
should  be he ld  i n  c u l t u r e  media so t h a t  t h e  i s s u e  of GH s e c r e t i o n  from cel ls  i n  
mic rograv i ty  can be i n v e s t i g a t e d .  F i n a l l y ,  i t  is  e s s e n t i a l  t h a t  t h e  rats be 
k i l l e d  a t  KSC i n  o r d e r  t o  prepare ce l l s  under cond i t ions  where t h e  p o s s i b i l i t y  
of p i ck ing  up contaminat ion  du r ing  c e l l  p r e p a r a t i o n  is v i r t u a l l y  e l imina ted .  
------ --- 
--
This  procedure i s  done r o u t i n e l y  i n  our l a b o r a t o r y  wi th  v i r t u a l l y  100% success .  
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B. The exper imenta l  p r o t o c o l  f o r  aim 112 of our approved ground based 
r e s e a r c h  and f l i g h t  experiment is  g iven  below. In essence ,  t h i s  experiment 
i nvo lves  t h e  s e p a r a t i o n ,  by CFES, of v a r i a n t  forms of t h e  human growth hormone 
molecule conta ined  i n  e i t h e r  s e c r e t o r y  g r a n u l e s l o r  a l k a l i n e  e x t r a c t s  of human 
p o s t  mortem p i t u i t a r y  t i s s u e .  
A i m  82 Experimental  P ro toco l  
A f f i n i t y  P u r i f i e d  Human P i t u i t a r y  Ext rac t /Granule  F r a c t i o n  
Continuous Flow 
E l e c t r o p h o r e s i s  
4 
F r a c t i o n s  (200) 
Analys is  Separa ted  GH 
With t h i s  approach we should be a b l e  t o  answer t h e  fo l lowing:  
1. Can t h e  CFES device  be u t i l i z e d  t o  p u r i f y  a hGH form which i s  
h igh  i n  b i o l o g i c a l  a c t i v i t y ,  bu t  low i n  immunoactivity? 
2. What are t h e  moleuclar forms of t h e  GH conta ined  i n  t h e s e  
f r a c t i o n s ?  
3.  Can t h e  amount of hGH processed through CFES be s i g n i f i c a n t l y  
i n c r e a s e d  i n  mic rograv i ty?  
Based on t h e  expe r i ences  of McDonnell Douglas r e s e a r c h e r s  with t h e  CFES 
dev ice  i n  mic rograv i ty ,  we a n t i c i p a t e  t h a t  "throughput" w i l l  be s i g n i f i c a n t l y  
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i nc reased  i n  microgravi ty .  
po ten t  form of hGH would be of c o n s i d e r a b l e  i n t e r e s t  t o  t h e  pharmaceut ica l  
i n d u s t r y  as w e l l  a s  t o  t h e  medical community. Obviously, any f i n d i n g s  from 
t h i s  experiment could s e r v e  as t h e  b a s i s  f o r  f u t u r e  work by t h e  such groups. 
The e l e c t r o p h o r e t i c  s e p a r a t i o n  of a b i o l o g i c a l l y  
GENERAL CONSIDERATIONS AND POTENTIAL PROBLEMS TO BE ADDRESSED I N  THIS - -- --- 
RESEARCH. 
S ince  i n  a i m  #2 we are d e a l i n g  with e x t r a c t / s u b c e l l u l a r  p a r t i c u l a t e  
material ,  t h e  sample f o r  t h e  a c t u a l  mic rograv i ty  experiment can be 
prepared  i n  t h e  PI'S l a b o r a t o r y  w e l l  ahead of t h e  launch d a t e  and be s t o r e d  i n  
a f r o z e n  s t a t e  u n t i l  t h e  t i m e  of e l e c t r o p h o r e s i s .  A f t e r  t h e  e l e c t r o p h o r e s i s  
run ,  t h e  200 samples  can be s t o r e d  a t  4°C u n t i l  r e t u r n  t o  Earth.  
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B/I = 1.4 
B/I = 0.5 
B/I = 4.6 
HIXED TYPE I TYPE II 
CELL TYPE 
Fig. 1. Immunological and b i o l o g i c a l  a c t i v i t i e s  of growth hormone r e l e a s e d  
from mixed, t ype  I and type  I1 somatotrophs over a f o u r  day c u l t u r e  
per iod .  Immunoassays were performed by R I A ;  b ioassays  by t h e  t i b i a l  
l i n e  assay i n  hypophysectomized rats. Cu l tu re  medium was MEM + 5% 
c a l f  serum and a n t i b i o t i c s .  
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ORIGINAL PAGE IS 
OF POOR QUALITY 
Fig. 2. (Top) Photomicrograph of 10 mm long  XM-50 hollow f i b e r  and i n  c r o s s  
s e c t i o n .  
w a l l .  
(Middle) Scanning e l e c t r o n  micrograph showing lumen and f i b e r  
(Bottom) Scanning micrograph of p i t u i t a r y  ce l l s  i n  hol low f i b e r .  
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580 1 I ~ T  
E = EMPTY CAPSULES 
n -MIXED CELLS 
I - TYPE I 
II = TYPE II 
(12 DAY IMPLANT) 
Fig. 3.  Responses of hypophysectomized rats receiving hollow fibers containing 
nothing (empty, E); mixed (M); type I (1) or type 11 (11) SomatotroPhs 
12 days post implantation. 
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ORIGINAL PAGE BS 
OF POOR QUALITY 
Fig. 4. E l e c t r o n  micrograph of f r e s h l y  d i s p e r s e d  rat  p i t u i t a r y  cel ls .  
t h e s e  ce l l s  are GH producers .  
s e c r e t o r y  g r a n u l e s  which are  known t o  c o n t a i n  GH. 
Most of 
Note t h e  large numbers of cy top la smic  
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ORIGiNAL PAGE IS 
OF POOR QUALITY 
Fig.  5. L igh t  scat ter  p r o f i l e s  of l i v e  p i t u i t a r y  c e l l s  be fo re  (A-C) and a f t e r  
(D-L) s o r t i n g .  
p re sence  of dopamine 
(Y-axis). 
s o r t e d  from reg ions  A (D-F, 2 X lo4 c e l l s ) ,  B (G-1, 5 X lo4  c e l l s ) ,  and 
C (J-L, 4 . 3  X lo4 c e l l s )  wi th  t h e  r i d g e s  marked a , b , c  on t h e  p r o f i l e s  
gene ra t ed  from t h e  u n f r a c t i o n a t e d  cel ls  (A-C, 7 X lo5 c e l l s ) .  
Cells from 46-day-old male ra ts  were d i s s o c i a t e d  i n  t h e  
M) and ana lyzed  f o r  PLS (X-axis) and FALS 
Note correspondence of t h e  l i g h t  s c a t t e r  p r o f i l e s  of c e l l s  
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Fig. 6 .  S e p a r a t i o n  of ra t  p i t u i t a r y  c e l l s  by CFES. Mobi l i ty  p r o f i l e s  of ce l l s  
are shown i n  pane ls  A , F , K  and N. I n t r a c e l l u l a r  GH and PRL c o n t e n t s  of 
c e l l s  ob ta ined  from pooled areas shown were determined by immunoassay. 
Percentages  of GH and PRL c o n t a i n i n g  c e l l  t ypes  i n  t h e s e  f r a c t i o n s  
were determined by immunohistochemistry. 
mic rograv i ty .  
t h e  t e x t .  
Exp. 82 was done i n  
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Fig. 7. GH r e l e a s e d  from GH ce l l s  s e p a r a t e d  by CFE. Cells i n  pooled 
e l e c t r o p h o r e s i s  f r a c t i o n s  5+6 and 10+11 ( s e e  Fig.  6 ,  Exp. 4 ,  pane l  0)  
were c u l t u r e d  f o r  s i x  days and t h e  GH r e l e a s e d  i n t o  t h e  medium was 
assayed  by R I A  and t i b i a l  l i n e  b ioassay .  The i n t r a c e l l u l a r  c o n t e n t s  
of GH i n  c e l l s  i n  t h e s e  pooled f r a c t i o n s  p r i o r  t o  c u l t u r e  are shown i n  
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IO 
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Fraction * 
Fig. 8. D i s t r i b u t i o n s  of GH and PRL c o n t a i n i n g  c e l l s  i n  f r a c t i o n s  a f t e r  CFES. 
These d i s t r i b u t i o n s  were determined from counts  of 30,000 
c e l l s / f r a c t i o n ,  a f t e r  s t a i n i n g  with hormone s p e c i f i c  an t ibody ,  by f low 
c y t  omet ry  . 
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Fig. 9. Two parameter flow cy tomet r i c  a n a l y s i s  of GH ce l l s  conta ined  i n  Fr.  5 
( t o p )  and Fr. 19 (bottom) a f t e r  t h e  CFES t r i a l  shown i n  Fig. 8. The 
i n t e n s i t y  of t h e  green  f l u o r e s c e n c e  (X axis) relates t o  t h e  presence  
of GH cells ,  while t h e  forward a n g l e  l i g h t  scatter (FALS, Y axis )  
relates t o  t h e  ce l l  s i z e .  Numbers of cel ls  counted are shown i n  upper 
r i g h t  corner .  The i n t e n s e l y  s t a i n e d  GH ce l l s  i n  Fr .  19 ( i d e n t i f i e d  by 
v ) are not p r e s e n t  i n  fr. 5. However, some less i n t e n s e l y  s t a i n e d  GH 
cel ls  are seen  i n  both f r a c t i o n s  (*I- 
ORIGINAL PAGE IS 
OF POOR QUALITY 
74 
Fig. 10. E l e c t r o n  micrograph of a human pos t  mortem p i t u i t a r y  gland 8 h r s .  
a f t e r  death. Although g e n e r a l  c e l l  a u t o l y s i s  i s  e v i d e n t ,  t h e  
GH-containing g r a n u l e s  are i n t a c t .  
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HUMAN POST MORTEM PITUITARY GRANULES 


























,q I I 
FRACTION NUMBER 
Fig. 11. D i s t r i b u t i o n  p r o f i l e  of immunoactive human GH conta ined  i n  CFE 
f r a c t i o n s  a f t e r  e l e c t r o p h o r e s i s  of a crude pe l le t  (20,000 X g )  
c o n t a i n i n g  g ranu les .  Although not shown on f i g u r e ,  t ubes  1-89 and 
141-200 were assayed and found not t o  c o n t a i n  GH. 
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2 - TUBES 88-103 
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14 = TUBES 1 14-200) 
Combined electrophoresis fraction 
Fig. 12. B i o l o g i c a l  a c t i v i t i e s  of hGH conta ined  i n  g ranu le  f r a c t i o n s  s e p a r a t e d  
by CFES. The experiment d e p i c t e d  i n  Fig. 11 r e s u l t e d  i n  200 tubes  
which were pooled i n t o  f o u r  a r e a s  shown i n  t h e  i n s e r t .  Hormone i n  
t h e s e  pooled f r a c t i o n s  was measured by immunoassay and t i b i a l  l i n e  
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1447 111t3 48 0.43 
58 6.7 3.1 0.46 
54 6.5 45.1 6.94 
725 245.7 128.1 0.52 
92 11.1 0.95 0.09 
Fig. 13. Fractionation of an alkaline extract of a human pituitary gland by 
HPLC and immunological/biological activities of the hGH contained in 
pooled fractions eluting from the SW300 sizing column. 
profile (at a setting of 1.0 full scale deflection) is shown in the 
upper panel and the hormone activities of the pooled areas are shown 
in the table (bottom). Biological activity of the hGH was determined 











































0 s  
Fig. 14. CFES of human p i t u i t a r y  e x t r a c t .  Fr .  #2 from a n  HPLC run  (see Fig. 
13) w a s  a p p l i e d  t o  CFES and t h e  r e s u l t i n g  200 tubes  were pooled 
( 1 5 / f r a c t i o n )  p r i o r  t o  a s s a y  by 3T3 ce l l  bioassay. 
shown i n  t h e  f i g u r e ,  on ly  20% of t h e  t o t a l  recovered immunoreactive 
hGH was a s s o c i a t e d  wi th  material i n  f r s .  1-5. 
Although not  
79 
hGH STANDARD HUMAN PITUITARY EXTRACT 
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Fig. 15. B i o l o g i c a l  and immunological a c t i v i t i e s  of hGH s t anda rd  and a human 
p i t u i t a r y  e x t r a c t  be fo re  and a f t e r  a f f i n i t y  chromatography. A h i g h l y  
po ten t  hGH an t i se rum was c o v a l e n t l y  coupled t o  P i e r c e  R e a c t i g e l  (see 
t e x t ) .  M a t e r i a l  Sound t o  t h e  column was removed by e l u t i o n  wi th  4M 
KSCN. 
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ORIGINAL PAGE IS 
OF POOR QUALtTY 
Fig.  16. Western b l o t  SDS-PAGE p r o f i l e s  of hGH con ta ined  i n  hormone s t a n d a r d  
o r  i n  human p i t u i t a r y  extract  b e f o r e  and a f t e r  a f f i n i t y  
chromatography. 
r e s p e c t i v e l y .  
e l u t i o n  from t h e  column wi th  KSCN. Note t h a t  v i r t u a l l y  no hGH 
immunoactivity i s  p r e s e n t  i n  t h e  pas s th rough  of e i t h e r  t h e  hGH 
s t a n d a r d  ( l a n e  3 )  or p i t u i t a r y  extract  (lane 6 ) .  
markers show m o b i l i t i e s  of known s t anda rds .  
d a t a .  
Lanes 1 and 4 show hGH i n  s t a n d a r d  o r  f r e s h  e x t r a c t  
Lanes 2 and 5 show t h e  appearance of hGH forms a f t e r  
Molecular  weight 






COMPARISONS OF TWO TYPES OF SOMATOTROPHS 
Type I Type I1 
1.050 - 1.068 1.071 - 1.086 
Few 
Abundant Regions of RER Few Regions of RER 
and Golgi Apparatus and Golgi Apparatus 
Db-CAMP ( 3  x 10" M) Stimulated Secretion Stimulated Secretion 
Somatostatin (10'~ M) Inhibited Secretion Inhibited Secretion 
Thyroxine (loa M) No Effect Stimulated Secretion 
Hydrocortisone ( M) Increased Cell GH No Effect 
~ ~ 
Snyder, G., W. Hymer, and J. Snyder, ENDOCRINOLOGY 101:788, 1977. 
TABLE 2 
HORMONE RELEASE FROM CELLS ON EARTH 
AFTER 7 DAYS IN MICROGRAVITY* 
UG Hormone Released+ UG Hormone Produced++ 
- 
GH PRL GH PRL 
E a r t h  16.8 3.3 12.9 1.6 
Space 0.8 5.0 0.2 4.9 
Cells flown f o r  7 days on STS-8 i n  September 1983. * 
+6 day c u l t u r e ;  1x106 ce l l s  i n  5 m l  aMEM + 5% c a l f  serum. 















Ko la t a ,  G. 
234, October 3, 1986, pp. 22-24. 
"New Growth I n d u s t r y  i n  Human Growth Xormone?," Sc ience ,  Vol. 
E l l i s ,  S. and R. E. Grindeland, "Dichotomy Between Bioassayable and 
Immunoassayable Growth Hormone," Advances -- i n  Human Growth Hormone 
Research, Washington, D. C. ,  U. S. Government P r i n t i n g  O f f i c e ,  DHEW 
P u b l i c a t i o n  No. (NIH) 74-612, 1974, pp. 409-433. 
Hymer, W. C. and J. H a t f i e l d ,  " P u r i f i c a t i o n  of Cells from t h e  A n t e r i o r  
P i t u i t a r y , "  i n  iqethods i n  Enzymology, Colourck and Kaplan, eds., Academic 
Press, Vol. 103, p a r t  h ,  ed., P. Conn, 1983, pp. 257-287. 
Hymer, W. C. and J. M. H a t f i e l d .  1984. Sepa ra t ion  of c e l l s  from t h e  r a t  
a n t e r i o r  p i t u i t a r y  gland. I n  Cell Sepa ra t ion :  Methods - and S e l e c t e d  
A p p l i c a t i o n s ,  ed. T. G. P re t low and T. Pretlow. 
pp. 163-194. 
Academic P r e s s ,  Vol. 3, 
Snyder,  G., W. C. Hymer and J. Snyder. 1977. Funct iona l  h e t e r o g e n e i t y  i n  
somatotrophs i s o l a t e d  from t h e  ra t  a n t e r i o r  p i t u i t a r y .  Endocrinology 
101:788-799. 
Gr inde land ,  R., W. C. Hymer, P. Lundgren and C. Edwards. D i f f e r e n t i a l  
s e c r e t i o n  of b ioas sayab le  growth hormone by two t y p e s  of ra t  somatotrophs,  
The P h y s i o l o g i s t ,  25 ( 4 ) ,  1982, pp. 262. -
Hymer, W. C., D. L. Wilbur,  R. Page, E. Hibbard,  R -  c-  Kelsey and J. 
H a t f i e l d .  P i t u i t a r y  hollow f i b e r  u n i t s  i n  v ivo  and i n  v i t r o .  
Neuroendocrinology, 32, 1981, pp 339-34x  - 
Hymer, W. C., M. Angeline,  M. Chu, R. Grindeland, J. Harkness, J. H a t i f i e l d ,  
E. Hibbard, K. Kovacs, G. Mansur, A. Mastro, K. Mot te r ,  J. Parsons ,  C. 
Phe lps ,  B. Ruskin, A. S i g n o r e l l a ,  W. Tay lo r ,  M. Thorner, G O  T i n d a l l  and D- 
Wilbur. Hollow F i b e r s :  T h e i r  a p p l i c a t i o n s  t o  t h e  s tudy  of mammmalian 
c e l l  func t ion .  Regu la t ion  of Targe t  - C e l l  Responsiveness,  Vol. 1, (Eds. K. W. 
McKerns, A. Aakvaag, and V.Hansson)  1984, ppe 407-461 (Plenum Pub l i sh ing  
Corp. 
H a t f i e l d ,  J. M. and W. C. Hymer. 1986. Flow cy tomet r i c  a n a l y s i s  and s o r t i n g  
of l i v e  male ra t  a n t e r i o r  p i t u i t a r y  c e l l  t ypes  by forward ang le  and 
pe rpend icu la r  l i g h t  s c a t t e r .  Endocrinology. 119:2670-2682. 
H a t f i e l d ,  J. M. and W. C. Hymer. 1986. Flow cy tomet r i c  a n a l y s i s  and s o r t i n g  
of l i v e  female rat a n t e r i o r  p i t u i t a r y  c e l l  t ypes  by forward ang le  and 
pe rpend icu la r  l i g h t  s c a t t e r :  E f f e c t  of 17B-Estradiol. Endocrinology. 
119:2683-2694. 
H a t f i e l d ,  J. M. and W. C. Hymer. 1985. Flow cy tomet r i c  immunofluorescence 
of ra t  a n t e r i o r  p i t u i t a r y  c e l l s .  Cytometry 6:137-142. 
Bolt-, R. C. and P. Todd. 1979. I n  E l e c t r o k i n e t i c  Sepa ra t ion  Methods 
( R i g h e t t i ,  P. G., Van Oss, C. J. and Vanderhoff,  J. W., eds.)  
Elsevier/North-Holland Biomedical Press, Amsterdam. 
229-250, 
84 
13. Plank, L. D., W. C. Hymer, M. E. Kunze, G. M. Marks, J. W. Lanham and P. 
Todd, A study of cell electrophoresis as a means of purifying growth 
hormone secreting cells. J. Biochem. Biophys. Methods, 9, 1983, pp. 
275-289. 
-
14. Hymer, W. C., Grant H. Barlow, Steven J. Blaisdell, Carolyn Cleveland, Mary 
Ann Farrington, Mary Feldmeier, Richard Grindeland, J. Michael Hatfield, J. 
Wayne Lanham, Marian L. lewis, Dennis R. Morrison, Barbara J. Olack, David W. 
Richman, James Rose, David W., Scharp, Robert S. Snyder, Carol A. Swanson, 
Paul Todd and William Wilfinger. 1987. Continuous Flow electrophoretic 
separation of proteins and cells from mammalian tissues. Cell Biophysics (in 
press). 
15. Science "News and Comment" Vol. 228, June 7, 1985. 
16.  Nixon, T. and H. Green. "Contribution of Growth Hormone to Adipogenic 
Activity of Serum," Endocrinology, Vol. 114, 1984, pp 527-532. 
17. Cogoli, A., A. Tschoop. and P. Fuchs-Bislin, "Cell Sensitivity to Gravity," 
Science, Vol. 225, 1984, pp. 228-230. 
18. Grindeland, R., W. C. Hymer, M. Farrington, T. Fast, C. Hayes, K. Motter, L. 
Patil and M. Vasques. 1987. Changes in pituitary growth hormone cells 










1447 11143 48 0.43 
58 6.7 3.1 0.40 
54 6.5 45.1 6.94 
725 245.7 128.1 0.52 
92 11.1 0.95 0.09 
TABLE 6 
F r a c t i o n a t i o n  of hGH by a f f i n i t y  chromotography 
Column+ 
Sample F r a c t i o n  
Immuno- 
B ioac t ive  hGH p o s i t i v e  
(IJ g)+  
P u r i f i e d  hGH a )  Unf rac t iona ted  0.9 
s t a n d a r d  s t a r t i n g  material 
b )  Pass through 5.6 
c )  Bound 4.8 
Crude a l k a l i n e  a )  Unf rac t iona ted  2.5 
e x t r a c t  of human s t a r t i n g  material 
p i t u i t a r y  gland 
b )  Pass through 2.6 







An IgG f r a c t i o n  of r a b b i t  an i t s e rum r a i s e d  a g a i n s t  hGH was coupled t o  P i e r c e  
a c t i v a t e d  immidazolyl-carbamaite ( F r a c t o g e l ) .  The s t a r t i n g  material was 
prepared  i n  0.01 M PBS and t h e  column run i n  t h i s  bu f fe r .  
e l u t e d  from t h e  column with 4M KSCN. 
Bound material was 
86 
TABLE 5 
GH a c t i v i t y  i n  c rude  g ranu le  f r a c t i o n s  of human pos t  mortem 
p i t u i t a r y  t i s s u e  a f t e r  cont inuous  f low e l e c t r o p h o r e s i s +  
Combined 
f r a c t i o n  number Immunoactive Bioact i v e  B / I  
e l e c t r o p h o r e s i s  Tube GH/f r a c t i o n  (ug) 
0-87 
88-103 











+11 h r  p o s t  mortem p i t u i t a r y  g land;  See Fig. 8 f o r  d i s t r i b u t i o n  of 
immunoactive GH i n  i n d i v i d u a l  f r a c t i o n s  from t h e  DFE device.  
*Determined by t i b i a l  l i n e  b ioassay .  
Table  4 
Immunological and b i o l o g i c a l  a c t i v i t i e s  of GH r e l e a s e d  
from ce l l s  i n t o  c u l t u r e  medium a f t e r  CFE 
I n t r a c e l l u l a r  GH Released GH 
(immunoassay) ug/750,000 ce l l s  






22 1 88 
+See Fig.  4, exp. 14 f o r  p o s i t i o n s  of ce l l s  mig ra t ing  t o  t h e s e  areas. 
"5x104 c e l l s / f r a c t i o n  c u l t u r e d  i n  200 u1 aMEM con ta in ing  c a l f  serum and 
a n t i b i o t i c s  i n  96 w e l l  plates ( 5  w e l l s / f r a c t i o n )  a t  37OC under 95% 
humidi f ied  a i r : 5 %  C02 f o r  e i g h t  days. 
R I A  o r  by t i b i a l  l i n e  b ioassay .  
GH i n  t h e s e  media were then  tested by 
87 
I n  summary, we  have used t h e  c e l l  s e p a r a t i o n  techniques  of v e l o c i t y  
sed imen ta t ion ,  f low cytometry and cont inuous  flow e l e c t r o p h o r e s i s  t o  o b t a i n  
e n r i c h e d  popu la t ions  of GH cel ls .  
subpopu la t ion  which releases GH molecules which a r e  very high i n  b i o l o g i c a l  
a c t i v i t y  (but  r e l a t i v e l y  poor i n  immmunological a c t i v i t y ) ,  i t  w i l l  be impor tan t  t o  
use  a method which can e f f e c t i v e l y  process  l a r g e  numbers of c e l l s  over a s h o r t  
t i m e  span. The techniques  based on sed imen ta t ion  are l i m i t e d  by c e l l - d e n s i t y  
o v e r l a p s  and streaming. 
d e n s i t i e s  t o  GH ( type  11) c e l l s .  While flow cytometry i s  u s e f u l  i n  t h e  a n a l y t i c a l  
mode f o r  o b j e c t i v e l y  e s t a b l i s h i n g  c e l l  p u r i t y ,  t h e  numbers of c e l l s  which can be 
processed  i n  t h e  s o r t  mode are so  small as t o  make t h i s  approach i n e f f e c t i v e  i n  
terms of our long  term goals .  We have shown t h a t  CFES can s e p a r a t e  GH c e l l s  from 
o t h e r  c e l l  t ypes  on t h e  b a s i s  of d i f f e r e n c e s  i n  s u r f a c e  charge. Impor t an t ly ,  t h e  
b i o a c t i v e  producers  a p p e a r  t o  be more e l e c t r o p h o r e t i c a l l y  mobile t h a n  t h e  low 
producers.  
i o n i c  s t r e n g t h  b u f f e r s  and poor c e l l  r e c o v e r i e s  from t h e  CFES device.  It seems 
l i k e l y  t h a t  f u t u r e  r e s e a r c h  w i l l  p a r t i a l l y  a l l e v i a t e  some of t h e s e  problems. The 
a l r e a d y  proven inc reased  throughput of t h e  CFES dev ice  i n  mic rograv i ty  should  
p rov ide  t h e  means t o  achieve  our u l t i m a t e  g o a l ,  - v iz .  t h e  l a r g e  scale p roduc t ion  of 
b ioproducing  c e l l s  so t h a t  i s o l a t i o n  and c h a r a c t e r i z a t i o n  of t h i s  b i o a c t i v e  GH 
form can be r e a l i z e d .  
S ince  our  u l t i m a t e  goa l  i s  t o  i s o l a t e  a GH c e l l  
For example, p i t u i t a r y  FSH/LH ce l l  types  have i d e n t i c a l  
Curren t  ground based CFES e f f o r t s  are hampered by c e l l  clumping i n  low 
' 8 8 ;  
